Keros Therapeutics Inc (KROS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Sales | 0 | 10,000 | 0 | 0 |
| Gross Profit | N/A | 10,000 | N/A | N/A |
| Operating Expenses | 46,657 | 20,563 | 0 | 0 |
| Operating Income | -46,657 | -10,563 | N/A | N/A |
| Interest Expense | 6 | 8 | 0 | 0 |
| Other Income | 1,130 | -1,765 | 0 | 0 |
| Pre-tax Income | -45,533 | -12,336 | 0 | 0 |
| Income Tax | -172 | N/A | N/A | N/A |
| Net Income Continuous | -45,361 | -12,336 | N/A | N/A |
| Net Income | $-45,361 | $-12,336 | $N/A | $N/A |
| EPS Basic Total Ops | -2.93 | -6.08 | N/A | N/A |
| EPS Basic Continuous Ops | -2.93 | -5.30 | N/A | N/A |
| EPS Diluted Total Ops | -2.93 | -6.08 | N/A | N/A |
| EPS Diluted Continuous Ops | -2.93 | -5.30 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -2.93 | N/A | N/A | N/A |
| EBITDA(a) | $-46,379 | $-10,355 | $N/A | $N/A |